These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 535183)

  • 21. Vascular lesions in women taking oral contraceptives.
    Irey NS; Manion WC; Taylor HB
    Arch Pathol; 1970 Jan; 89(1):1-8. PubMed ID: 4188605
    [No Abstract]   [Full Text] [Related]  

  • 22. [A new estrogen variant in the oral contraceptive Non-Ovlon].
    Sarembe B
    Dtsch Gesundheitsw; 1973; 28(5):223-7. PubMed ID: 4579102
    [No Abstract]   [Full Text] [Related]  

  • 23. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
    Cole JA; Norman H; Doherty M; Walker AM
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study of low-dose oral contraceptives (with low-doses of ethinyl estradiol), widely used in practice].
    Nalbanski B; Tsekova K; Ivanov S
    Akush Ginekol (Sofiia); 2001; 41 Suppl 4():20-3. PubMed ID: 11519317
    [No Abstract]   [Full Text] [Related]  

  • 25. [Giant cell thromboangiitis in a patient taking an oral contraceptive (author's transl)].
    Bakouche P; Vedrenne C; Beaumont V; Chaouat D; Reignier A; Nick J
    Rev Neurol (Paris); 1980; 136(8-9):509-19. PubMed ID: 7221328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Peroral contraceptives and thromboembolism].
    Asperger Z
    Lijec Vjesn; 1969 Jul; 91(7):779-82. PubMed ID: 4910828
    [No Abstract]   [Full Text] [Related]  

  • 27. Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.
    Heuser P; Tonga K; Hopkins R; Henderson M; Weatherall M; Metcalfe S; Beasley R
    N Z Med J; 2004 Nov; 117(1206):U1176. PubMed ID: 15570345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oral contraception and cerebrovascular accidents].
    Nick J; Bakouche P; Beaumont V; Vedrenne C
    Bull Acad Natl Med; 1981 Jun; 165(6):723-30. PubMed ID: 7034891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical experiences with a new peroral contraceptive].
    Block E; Fosnes A; Klottrup P; Lundin W; Sjöstedt S
    Lakartidningen; 1972 May; 69(22):2679-82. PubMed ID: 5068977
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiethinyl estradiol antibodies.
    Beaumont JL
    Neurology; 1993 Sep; 43(9):1860-1. PubMed ID: 8414056
    [No Abstract]   [Full Text] [Related]  

  • 31. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
    van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM
    Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thrombelastography and oral contraceptives].
    Delacrétaz-Dubugnon F
    Schweiz Med Wochenschr; 1972 Jan; 102(2):48-52. PubMed ID: 4644685
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vascular risk of oral contraceptive agents: realities and mechanisms. II. Mechanisms of vascular accidents: their prevention].
    Beaumont V; Beaumont JL
    Presse Med; 1989 Jun; 18(25):1249-53. PubMed ID: 2525774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenteric vein thrombosis associated with oral contraceptive administration during pregnancy.
    Friedman M; Zimmer EZ; Graubard ZG
    Ann Chir Gynaecol; 1984; 73(5):296-8. PubMed ID: 6524863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adverse effects of oral contraceptives].
    Adam H; Schirmer B
    Z Arztl Fortbild (Jena); 1973 Nov; 67(21):1078-81. PubMed ID: 4130135
    [No Abstract]   [Full Text] [Related]  

  • 36. Contraceptive hormones, vascular risk, and abnormal precipitation of serum gamma-globulins.
    Beaumont V; Lemort N; Lorenzelli L; Mosser AM; Beaumont JL
    Sem Hop Paris; 1979 Mar 18-25; 55(11-12):5850591. PubMed ID: 12278180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisteroid immune complexes and vascular thrombosis during steroid hormone therapy.
    van den Brûle FA; Coibion M; Hendrick JC; Gaspard UJ
    Contraception; 1994 Jun; 49(6):571-7. PubMed ID: 8070262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Practical experience with a new contraceptive of the modified sequential type].
    Welti H
    Rev Med Suisse Romande; 1972 Oct; 92(10):785-95. PubMed ID: 4660891
    [No Abstract]   [Full Text] [Related]  

  • 39. [Search for new ways with low dose contraceptive agents. I].
    Tóth F; Gimes R; Horn B; Kerényi T
    Z Arztl Fortbild (Jena); 1972 Oct; 66(19):957-63. PubMed ID: 4636589
    [No Abstract]   [Full Text] [Related]  

  • 40. [3 cases of cataract occurring in women taking the same oral contraceptive. Is this a coincidence?].
    Goddé-Jolly D; Ruellan YM; Bremme C; Théron HP
    Bull Soc Ophtalmol Fr; 1972 Apr; 12(4):441-2. PubMed ID: 4659442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.